Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
Nature Medicine2016Vol. 22(4), pp. 427–432
Citations Over TimeTop 1% of 2016 papers
Roman Camarda, Alicia Y. Zhou, Rebecca A. Kohnz, Sanjeev Balakrishnan, Céline I. Mahieu, Brittany Anderton, Henok Eyob, Shingo Kajimura, Aaron D. Tward, Gregor Krings, Daniel K. Nomura, Andrei Goga
Related Papers
- → The response to neoadjuvant chemotherapy and prognosis of triple-negative breast cancer patients.(2009)1 cited
- → A comparison of triple negative versus triple positive breast cancers(2011)
- → COMPARISON OF CLINICO-PATHOLOGICAL FEATURES AND PROGNOSIS OF TRIPLE-NEGATIVE AND NON-TRIPLE-NEGATIVE FEMALE BREAST CANCER PATIENTS(2018)
- → Treatment of triple negative breast cancer(2013)
- → PO121 A COMPARISON OF CLINICOPATHOLOGICAL FEATURES AND PROGNOSIS BETWEEN TRIPLE-NEGATIVE AND NON-TRIPLE NEGATIVE BREAST CANCER AT OCEAN ROAD CANCER INSTITUTE(2023)